St3Gal-IV Antibodies

Santa Cruz Biotechnology offers a broad range of St3Gal-IV monoclonal antibodies for research in glycosylation and cell signaling. St3Gal-IV monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). St3Gal-IV, or ST3 beta-galactoside alpha-2,3-sialyltransferase IV, plays a crucial role in the biosynthesis of sialylated glycoconjugates, which are important for cell-cell interactions, immune response modulation, and the development of various tissues. Understanding St3Gal-IV function is essential for elucidating its involvement in pathological conditions, including cancer and neurodegenerative diseases. St3Gal-IV research has revealed significant insights into cellular communication and disease progression. Researchers have identified multiple regulatory mechanisms that control St3Gal-IV expression and activity in different cellular environments. Recent studies have highlighted St3Gal-IV's significance in immune cell trafficking and tumor metastasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of St3Gal-IV's role in health and disease.